|
1
|
Bray F, Laversanne M, Sung H, Ferlay J,
Siegel RL, Soerjomataram I and Jemal A: Global cancer statistics
2022: GLOBOCAN estimates of incidence and mortality worldwide for
36 cancers in 185 countries. CA Cancer J Clin. 74:229–263.
2024.PubMed/NCBI
|
|
2
|
Smyth EC, Nilsson M, Grabsch HI, van
Grieken NCT and Lordick F: Gastric cancer. Lancet. 396:635–648.
2020. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
de Martel C, Georges D, Bray F, Ferlay J
and Clifford GM: Global burden of cancer attributable to infections
in 2018: A worldwide incidence analysis. Lancet Glob Health.
8:e180–e190. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Plummer M, Franceschi S, Vignat J, Forman
D and de Martel C: Global burden of gastric cancer attributable to
Helicobacter pylori. Int J Cancer. 136:487–490. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Wroblewski LE, Peek RM Jr and Wilson KT:
Helicobacter pylori and gastric cancer: Factors that
modulate disease risk. Clin Microbiol Rev. 23:713–739. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Amieva M and Peek RM Jr: Pathobiology of
Helicobacter pylori-induced gastric cancer.
Gastroenterology. 150:64–78. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Polk DB and Peek RM Jr: Helicobacter
pylori: Gastric cancer and beyond. Nat Rev Cancer. 10:403–414.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Wizenty J and Sigal M: Helicobacter
pylori, microbiota and gastric cancer-principles of
microorganism-driven carcinogenesis. Nat Rev Gastroenterol Hepatol.
22:296–313. 2025. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Correa P: Human gastric carcinogenesis: A
multistep and multifactorial process-first American cancer society
award lecture on cancer epidemiology and prevention. Cancer Res.
52:6735–6740. 1992.PubMed/NCBI
|
|
10
|
Liabeuf D, Oshima M, Stange DE and Sigal
M: Stem cells, Helicobacter pylori, and mutational
landscape: Utility of preclinical models to understand
carcinogenesis and to direct management of gastric cancer.
Gastroenterology. 162:1067–1087. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Malfertheiner P, Megraud F, Rokkas T,
Gisbert JP, Liou JM, Schulz C, Gasbarrini A, Hunt RH, Leja M,
O'Morain C, et al: Management of Helicobacter pylori
infection: The Maastricht VI/Florence consensus report. Gut.
71:1724–1762. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Dinis-Ribeiro M, Libânio D, Uchima H,
Spaander MCW, Bornschein J, Matysiak-Budnik T, Tziatzios G,
Santos-Antunes J, Areia M, Chapelle N, et al: Management of
epithelial precancerous conditions and early neoplasia of the
stomach (MAPS III): European society of gastrointestinal endoscopy
(ESGE), European Helicobacter and microbiota study group (EHMSG)
and European society of pathology (ESP) guideline update 2025.
Endoscopy. 57:504–554. 2025. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Chen HN, Wang Z, Li X and Zhou ZG:
Helicobacter pylori eradication cannot reduce the risk of
gastric cancer in patients with intestinal metaplasia and
dysplasia: Evidence from a meta-analysis. Gastric Cancer.
19:166–175. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Fu Q, Yu H, Liu M, Chen L, Chen W, Wang Z
and Li W: Effect of Helicobacter pylori eradication on
gastric cancer risk in patients with intestinal metaplasia or
dysplasia: A meta-analysis of randomized controlled trials. Front
Microbiol. 16:15305492025. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Hung KH, Wu JJ, Yang HB, Su LJ and Sheu
BS: Host Wnt/beta-catenin pathway triggered by Helicobacter
pylori correlates with regression of gastric intestinal
metaplasia after H. pylori eradication. J Med Microbiol.
58:567–576. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Kodama M, Okimoto T, Mizukami K, Hirashita
Y, Wada Y, Fukuda M, Matsunari O, Okamoto K, Ogawa R, Fukuda K, et
al: Gastric mucosal changes, and sex differences therein, after
Helicobacter pylori eradication: A long-term prospective
follow-up study. J Gastroenterol Hepatol. 36:2210–2216. 2021.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Shah SC, Wang AY, Wallace MB and Hwang JH:
AGA clinical practice update on screening and surveillance in
individuals at increased risk for gastric cancer in the United
States: Expert review. Gastroenterology. 168:405–416.e1. 2025.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Park JY: Population-based Helicobacter
pylori screen-and-treat strategies for gastric cancer
prevention: Guidance on implementation. IARC Working Group Reports
Lyon (FR): International Agency for Research on Cancer; 2025
|
|
19
|
Lee YC, Chiang TH, Chou CK, Tu YK, Liao
WC, Wu MS and Graham DY: Association between Helicobacter
pylori eradication and gastric cancer incidence: A systematic
review and meta-analysis. Gastroenterology. 150:1113–1124.e5. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Ford AC, Yuan Y, Park JY, Forman D and
Moayyedi P: Eradication therapy to prevent gastric cancer in
Helicobacterpylori-positive individuals: Systematic review
and meta-analysis of randomized controlled trials and observational
studies. Gastroenterology. 169:261–276. 2025. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Choi IJ, Kook MC, Kim YI, Cho SJ, Lee JY,
Kim CG, Park B and Nam BH: Helicobacter pylori therapy for
the prevention of metachronous gastric cancer. N Engl J Med.
378:1085–1095. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Choi IJ, Kim CG, Lee JY, Kim YI, Kook MC,
Park B and Joo J: Family history of gastric cancer and
Helicobacter pylori treatment. N Engl J Med. 382:427–436.
2020. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Fukase K, Kato M, Kikuchi S, Inoue K,
Uemura N, Okamoto S, Terao S, Amagai K, Hayashi S and Asaka M;
Japan Gast Study Group, : Effect of eradication of Helicobacter
pylori on incidence of metachronous gastric carcinoma after
endoscopic resection of early gastric cancer: An open-label,
randomised controlled trial. Lancet. 372:392–397. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Rokkas T, Rokka A and Portincasa P: A
systematic review and meta-analysis of the role of Helicobacter
pylori eradication in preventing gastric cancer. Ann
Gastroenterol. 30:414–423. 2017.PubMed/NCBI
|
|
25
|
Rugge M, Genta RM, Fassan M, Valentini E,
Coati I, Guzzinati S, Savarino E, Zorzi M, Farinati F and
Malfertheiner P: OLGA gastritis staging for the prediction of
gastric cancer risk: A long-term follow-up study of 7436 patients.
Am J Gastroenterol. 113:1621–1628. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Capelle LG, de Vries AC, Haringsma J, Ter
Borg F, de Vries RA, Bruno MJ, van Dekken H, Meijer J, van Grieken
NCT and Kuipers EJ: The staging of gastritis with the OLGA system
by using intestinal metaplasia as an accurate alternative for
atrophic gastritis. Gastrointest Endosc. 71:1150–1158. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Dixon MF, Genta RM, Yardley JH and Correa
P: Classification and grading of gastritis: The updated sydney
system. International workshop on the histopathology of gastritis,
houston 1994. Am J Surg Pathol. 20:1161–1181. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Pimentel-Nunes P, Libânio D, Marcos-Pinto
R, Areia M, Leja M, Esposito G, Garrido M, Kikuste I, Megraud F,
Matysiak-Budnik T, et al: Management of epithelial precancerous
conditions and lesions in the stomach (MAPS II): European society
of gastrointestinal endoscopy (ESGE), European Helicobacter and
microbiota study group (EHMSG), European society of pathology
(ESP), and sociedade portuguesa de endoscopia digestiva (SPED)
guideline update 2019. Endoscopy. 51:365–388. 2019.PubMed/NCBI
|
|
29
|
Sugano K, Tack J, Kuipers EJ, Graham DY,
El-Omar EM, Miura S, Haruma K, Asaka M, Uemura N, Malfertheiner P,
et al: Kyoto global consensus report on Helicobacter pylori
gastritis. Gut. 64:1353–1367. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
den Hollander WJ, Holster IL, den Hoed CM,
Capelle LG, Tang TJ, Anten MP, Prytz-Berset I, Witteman EM, ter
Borg F, Hartog G, et al: Surveillance of premalignant gastric
lesions: A multicentre prospective cohort study from low incidence
regions. Gut. 68:585–593. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Marcos P, Brito-Gonçalves G, Libânio D,
Pita I, Castro R, Sá I, Dinis-Ribeiro M and Pimentel-Nunes P:
Endoscopic grading of gastric intestinal metaplasia on risk
assessment for early gastric neoplasia: Can we replace histology
assessment also in the west? Gut. 69:1762–1768. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
El-Omar EM, Carrington M, Chow WH, McColl
KE, Bream JH, Young HA, Herrera J, Lissowska J, Yuan CC, Rothman N,
et al: Interleukin-1 polymorphisms associated with increased risk
of gastric cancer. Nature. 404:398–402. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
González CA, Sala N and Capellá G: Genetic
susceptibility and gastric cancer risk. Int J Cancer. 100:249–260.
2002. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Tsugane S and Sasazuki S: Diet and the
risk of gastric cancer: Review of epidemiological evidence. Gastric
Cancer. 10:75–83. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Sung JJY, Coker OO, Chu E, Szeto CH, Luk
STY, Lau HCH and Yu J: Gastric microbes associated with gastric
inflammation, atrophy and intestinal metaplasia 1 year after
Helicobacter pylori eradication. Gut. 69:1572–1580. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Song CH, Choi Y, Kim N, Ha S, Park JH, Lee
HK, Shin CM and Ahn S: Longitudinal remodeling of gastric
microbiota following Helicobacter pylori eradication reveals
an eradication-associated microbial signature in gastric cancer.
Front Cell Infect Microbiol. 16:18484372026. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Ferreira RM, Pereira-Marques J,
Pinto-Ribeiro I, Costa JL, Carneiro F, Machado JC and Figueiredo C:
Gastric microbial community profiling reveals a dysbiotic
cancer-associated microbiota. Gut. 67:226–236. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Coker OO, Dai Z, Nie Y, Zhao G, Cao L,
Nakatsu G, Wu WKK, Wong SH, Chen Z, Sung JJY and Yu J: Mucosal
microbiome dysbiosis in gastric carcinogenesis. Gut. 67:1024–1032.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Gantuya B, El-Serag HB, Matsumoto T, Ajami
NJ, Oyuntsetseg K, Azzaya D, Uchida T and Yamaoka Y: Gastric
microbiota in Helicobacter pylori-negative and -positive
gastritis among high incidence of gastric cancer area. Cancers
(Basel). 11:5042019. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Salama NR, Hartung ML and Müller A: Life
in the human stomach: Persistence strategies of the bacterial
pathogen Helicobacter pylori. Nat Rev Microbiol. 11:385–399.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Backert S, Tegtmeyer N and Fischer W:
Composition, structure and function of the Helicobacter
pylori cag pathogenicity island encoded type IV secretion
system. Future Microbiol. 10:955–965. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Hatakeyama M: Oncogenic mechanisms of the
Helicobacter pylori CagA protein. Nat Rev Cancer. 4:688–694.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Cover TL and Blaser MJ: Helicobacter
pylori in health and disease. Gastroenterology. 136:1863–1873.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Boquet P and Ricci V: Intoxication
strategy of Helicobacter pylori VacA toxin. Trends
Microbiol. 20:165–174. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Fischer W: Assembly and molecular mode of
action of the Helicobacter pylori Cag type IV secretion
apparatus. FEBS J. 278:1203–1212. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Murata-Kamiya N, Kurashima Y, Teishikata
Y, Yamahashi Y, Saito Y, Higashi H, Aburatani H, Akiyama T, Peek RM
Jr, Azuma T and Hatakeyama TM: Helicobacter pylori CagA
interacts with E-cadherin and deregulates the beta-catenin signal
that promotes intestinal transdifferentiation in gastric epithelial
cells. Oncogene. 26:4617–4626. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Bessède E, Dubus P, Mégraud F and Varon C:
Helicobacter pylori infection and stem cells at the origin
of gastric cancer. Oncogene. 34:2547–2555. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Hayakawa Y, Fox JG and Wang TC: The
origins of gastric cancer from gastric stem cells: Lessons from
mouse models. Cell Mol Gastroenterol Hepatol. 3:331–338. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Houghton J, Stoicov C, Nomura S, Rogers
AB, Carlson J, Li H, Cai X, Fox JG, Goldenring JR and Wang TC:
Gastric cancer originating from bone marrow-derived cells. Science.
306:1568–1571. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Kusters JG, van Vliet AHM and Kuipers EJ:
Pathogenesis of Helicobacter pylori infection. Clin
Microbiol Rev. 19:449–490. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Peek RM Jr and Blaser MJ: Helicobacter
pylori and gastrointestinal tract adenocarcinomas. Nat Rev
Cancer. 2:28–37. 2002. View
Article : Google Scholar : PubMed/NCBI
|
|
52
|
Uemura N, Okamoto S, Yamamoto S, Matsumura
N, Yamaguchi S, Yamakido M, Taniyama K, Sasaki N and Schlemper RJ:
Helicobacter pylori infection and the development of gastric
cancer. N Engl J Med. 345:784–789. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Ihan A, Tepez B, Gubina M, Malovrh T and
Kopitar A: Diminished interferon-gamma production in gastric mucosa
T lymphocytes after H. pylori eradication in duodenal ulcer
patients. Hepatogastroenterology. 46:1740–1745. 1999.PubMed/NCBI
|
|
54
|
Kim MJ, Je Y, Chun J, Youn YH, Park H,
Nahm JH and Kim JH: Helicobacter pylori eradication is
associated with a reduced risk of metachronous gastric neoplasia by
restoring immune function in the gastric mucosa. Helicobacter.
30:e700302025. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Fu Y, Tong J, Zhu M, Xu L, Huang F, Zhang
Y, Wang X, Wang Z, Zhang J, Lv J, et al: Helicobacter
pylori-induced inflammatory cancer transformation
microenvironment drives gastric carcinogenesis. Cell Mol
Gastroenterol Hepatol. 20:1017572026. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Huang KK, Ma H, Chong RHH, Uchihara T,
Lian BSX, Zhu F, Sheng T, Srivastava S, Tay ST, Sundar R, et al:
Spatiotemporal genomic profiling of intestinal metaplasia reveals
clonal dynamics of gastric cancer progression. Cancer Cell.
41:2019–2037.e8. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Kim H, Kim J, Jeong IH, Park E, Yoo M,
Yoon S, Lee D, Myung J, Choi E, Goldenring JR and Jang B: Hybrid
identity and distinct methylation profiles of incomplete intestinal
metaplasia in the stomach. Gut. 75:10–23. 2026. View Article : Google Scholar
|
|
58
|
Curtius K, Wright NA and Graham TA: An
evolutionary perspective on field cancerization. Nat Rev Cancer.
18:19–32. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Collins GS, Reitsma JB, Altman DG and
Moons KGM: Transparent reporting of a multivariable prediction
model for individual prognosis or diagnosis (TRIPOD): The TRIPOD
statement. Ann Intern Med. 162:55–63. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
60
|
McShane LM, Altman DG, Sauerbrei W, Taube
SE, Gion M and Clark GM; Statistics Subcommittee of the NCI-EORTC
Working Group on Cancer Diagnostics, : REporting recommendations
for tumour MARKer prognostic studies (REMARK). Br J Cancer.
93:387–391. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
61
|
Hu W, Chen ZM, Wang Y, Yang C, Wu ZY, You
LJ, Zhai ZY, Huang ZY, Zhou P, Huang SL, et al: Single-cell RNA
sequencing dissects the immunosuppressive signatures in
Helicobacter pylori-infected human gastric ecosystem. Nat
Commun. 16:39032025. View Article : Google Scholar : PubMed/NCBI
|
|
62
|
Huang RJ, Wichmann IA, Su A, Sathe A, Shum
MV, Grimes SM, Meka R, Almeda A, Bai X, Shen J, et al: A spatial
transcriptomic signature of 26 genes resolved at single-cell
resolution characterizes high-risk gastric cancer precursors. NPJ
Precis Oncol. 9:522025. View Article : Google Scholar : PubMed/NCBI
|
|
63
|
Koch MRA, Gong R, Friedrich V,
Engelsberger V, Kretschmer L, Wanisch A, Jarosch S, Ralser A, Lugen
B, Quante M, et al: CagA-specific gastric CD8+
tissue-resident T cells control Helicobacter pylori during
the early infection phase. Gastroenterology. 164:550–566. 2023.
View Article : Google Scholar : PubMed/NCBI
|
|
64
|
Law AMK, Chen J, Colino-Sanguino Y,
Rodriguez de la Fuente L, Fang G, Grimes SM, Lu H, Huang RJ, Boyle
ST, Venhuizen J, et al: ALTEN: A high-fidelity primary
tissue-engineering platform to assess cellular responses ex vivo.
Adv Sci (Weinh). 9:e21033322022. View Article : Google Scholar : PubMed/NCBI
|
|
65
|
Wolff RF, Moons KGM, Riley RD, Whiting PF,
Westwood M, Collins GS, Reitsma JB, Kleijnen J and Mallett S;
PROBAST Group†, : PROBAST: A tool to assess the risk of bias and
applicability of prediction model studies. Ann Intern Med.
170:51–58. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
66
|
Vickers AJ and Elkin EB: Decision curve
analysis: A novel method for evaluating prediction models. Med
Decis Making. 26:565–574. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
67
|
Netea MG, Domínguez-Andrés J, Barreiro LB,
Chavakis T, Divangahi M, Fuchs E, Joosten LAB, van der Meer JWM,
Mhlanga MM, Mulder WJM, et al: Defining trained immunity and its
role in health and disease. Nat Rev Immunol. 20:375–388. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
68
|
Szabo PA, Miron M and Farber DL: Location,
location, location: Tissue resident memory T cells in mice and
humans. Sci Immunol. 4:eaas96732019. View Article : Google Scholar : PubMed/NCBI
|
|
69
|
Sorini C, Tripathi KP, Wu S, Higdon SM,
Wang J, Cheng L, Banerjee S, Reinhardt A, Kreslavsky T, Thorell A,
et al: Metagenomic and single-cell RNA-Seq survey of the
Helicobacter pylori-infected stomach in asymptomatic
individuals. JCI Insight. 8:e1610422023. View Article : Google Scholar : PubMed/NCBI
|
|
70
|
Li N, Chen S, Xu X, Wang H, Zheng P, Fei
X, Ke H, Lei Y, Zhou Y, Yang X, et al: Single-cell transcriptomic
profiling uncovers cellular complexity and microenvironment in
gastric tumorigenesis associated with Helicobacter pylori. J
Adv Res. 74:471–491. 2025. View Article : Google Scholar : PubMed/NCBI
|
|
71
|
Nowicki-Osuch K, Zhuang L, Cheung TS,
Black E, Masqué-Soler N, Devonshire G, Redmond A, Freeman A, di
Pietro M, Pilonis N, et al: Single-cell RNA sequencing unifies
developmental programs of esophageal and gastric intestinal
metaplasia. Cancer Discov. 13:1346–1363. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
72
|
Kim J, Park C, Kim KH, Kim EH, Kim H, Woo
JK, Seong JK, Nam KT, Lee YC and Cho SY: Single-cell analysis of
gastric pre-cancerous and cancer lesions reveals cell lineage
diversity and intratumoral heterogeneity. NPJ Precis Oncol.
6:92022. View Article : Google Scholar : PubMed/NCBI
|
|
73
|
Chen X, Jiang X, Wang S, Xia J, Wang W, Fu
X, Yukun P, Liu Z, Li Y, Zhang M and Ding Y: Integrated single-cell
and spatial transcriptomics reveal the differentiation drivers of
gastric epithelial lineage progression. Front Immunol.
17:17128302026. View Article : Google Scholar : PubMed/NCBI
|
|
74
|
Ye Y, Gong X, Liu S, Hu N, Zhang H, Fei X,
Huang A, Fan W, Chen Z, Wang H, et al: A single-cell multi-omics
atlas defines the cellular and molecular landscape of gastric
intestinal metaplasia. J Transl Med. 24:7242026. View Article : Google Scholar : PubMed/NCBI
|
|
75
|
Yin H, Zhang H, Zheng S, Guo R, Wen J, Liu
M, Li A, Zhao M, Yuan Y and Gong Y: Dissecting the differentiation
origins of intestinal metaplasia and early intestinal-type gastric
cancer in gastric antrum by single-cell RNA profiling. NPJ Precis
Oncol. 10:1672026. View Article : Google Scholar : PubMed/NCBI
|
|
76
|
Tsai CJ, Herrera-Goepfert R, Tibshirani
RJ, Yang S, Mohar A, Guarner J and Parsonnet J: Changes of gene
expression in gastric preneoplasia following Helicobacter
pylori eradication therapy. Cancer Epidemiol Biomarkers Prev.
15:272–280. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
77
|
Kumar V, Ramnarayanan K, Sundar R,
Padmanabhan N, Srivastava S, Koiwa M, Yasuda T, Koh V, Huang KK,
Tay ST, et al: Single-cell atlas of lineage states, tumor
microenvironment and subtype-specific expression programs in
gastric cancer. Cancer Discov. 12:670–691. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
78
|
Zhang M, Hu S, Min M, Ni Y, Lu Z, Sun X,
Wu J, Liu B, Ying X and Liu Y: Dissecting transcriptional
heterogeneity in primary gastric adenocarcinoma by single cell RNA
sequencing. Gut. 70:464–475. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
79
|
Murray PJ, Allen JE, Biswas SK, Fisher EA,
Gilroy DW, Goerdt S, Gordon S, Hamilton JA, Ivashkiv LB, Lawrence
T, et al: Macrophage activation and polarization: Nomenclature and
experimental guidelines. Immunity. 41:14–20. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
80
|
Su Z, He Y, You L, Chen J, Zhang G and Liu
Z: SPP1+ macrophages and FAP+ fibroblasts promote the progression
of pMMR gastric cancer. Sci Rep. 14:262212024. View Article : Google Scholar : PubMed/NCBI
|
|
81
|
Qiu L, Zhao X, Yao S, Fei Y, Gong Y, Zhou
Z, Jiao S and Xu J: Multi-omics analyses reveal interactions
between GREM1+ fibroblasts and SPP1+ macrophages in gastric cancer.
NPJ Precis Oncol. 9:1642025. View Article : Google Scholar : PubMed/NCBI
|
|
82
|
Ma G, Liu X, Jiang Q, Li S, Wu Q, Liang B,
Sun F, Gu C, Liao W, Zhang Z, et al: Identification of a stromal
immunosuppressive barrier orchestrated by
SPP1+/C1QC+ macrophages and CD8+
exhausted T cells driving gastric cancer immunotherapy resistance.
Front Immunol. 16:16185912025. View Article : Google Scholar : PubMed/NCBI
|
|
83
|
Lundgren A, Suri-Payer E, Enarsson K,
Svennerholm AM and Lundin BS: Helicobacter pylori-specific
CD4+ CD25high regulatory T cells suppress memory T-cell responses
to H. pylori in infected individuals. Infect Immun.
71:1755–1762. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
84
|
Amedei A, Cappon A, Codolo G, Cabrelle A,
Polenghi A, Benagiano M, Tasca E, Azzurri A, D'Elios MM, DelPrete G
and de Bernard M: The neutrophil-activating protein of
Helicobacter pylori promotes Th1 immune responses. J Clin
Invest. 116:1092–1101. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
85
|
Rad R, Brenner L, Bauer S, Schwendy S,
Layland L, da Costa CP, Reindl W, Dossumbekova A, Friedrich M, Saur
D, et al: CD25+/Foxp3+ T cells regulate gastric inflammation and
Helicobacter pylori colonization in vivo. Gastroenterology.
131:525–537. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
86
|
Kao JY, Zhang M, Miller MJ, Mills JC, Wang
B, Liu M, Eaton KA, Zou W, Berndt BE, Cole TS, et al:
Helicobacter pylori immune escape is mediated by dendritic
cell-induced Treg skewing and Th17 suppression in mice.
Gastroenterology. 138:1046–1054. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
87
|
Oertli M, Noben M, Engler DB, Semper RP,
Reuter S, Maxeiner J, Gerhard M, Taube C and Müller A:
Helicobacter pylori γ-glutamyl transpeptidase and
vacuolating cytotoxin promote gastric persistence and immune
tolerance. Proc Natl Acad Sci USA. 110:3047–3052. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
88
|
Hitzler I, Sayi A, Kohler E, Engler DB,
Koch KN, Hardt WD and Müller A: Caspase-1 has both proinflammatory
and regulatory properties in Helicobacter infections, which are
differentially mediated by its substrates IL-1β and IL-18. J
Immunol. 188:3594–3602. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
89
|
Caruso R, Pallone F and Monteleone G:
Emerging role of IL-23/IL-17 axis in H pylori-associated pathology.
World J Gastroenterol. 13:5547–5551. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
90
|
Xia T, Zhang Z, Xie J, Yuan H, Ren Y, Xu
Y, Ning J, Li B and Wu C: Gastric mucosal CD8+TRM cells
are recruited through CXCR5-CXCL13 axis in Helicobacter
pylori infected subjects. Cytokine. 190:1569042025. View Article : Google Scholar : PubMed/NCBI
|
|
91
|
Gong R, Huang B, Ralser A, Friedrich V,
Mibus C, Engelsberger V, Koch MRA, Skerhut M, Giese T, Andrä I, et
al: CagA-dependent Hobit+ gastric tissue-resident memory
T cells confer full protection from Helicobacter pylori
reinfection. Gut. 74:1792–1803. 2025. View Article : Google Scholar : PubMed/NCBI
|
|
92
|
Bockerstett KA, Lewis SA, Noto CN, Ford
EL, Saenz JB, Jackson NM, Ahn TH, Mills JC and DiPaolo RJ: Single-
cell transcriptional analyses identify lineage-specific epithelial
responses to inflammation and metaplastic development in the
gastric corpus. Gastroenterology. 159:2116–2129.e4. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
93
|
Petersen CP, Mills JC and Goldenring JR:
Murine models of gastric corpus preneoplasia. Cell Mol
Gastroenterol Hepatol. 3:11–26. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
94
|
Nam KT, Lee HJ, Sousa JF, Weis VG, O'Neal
RL, Finke PE, Romero-Gallo J, Shi G, Mills JC, Peek RM Jr, et al:
Mature chief cells are cryptic progenitors for metaplasia in the
stomach. Gastroenterology. 139:2028–2037.e9. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
95
|
Goldenring JR and Nam KT: Oxyntic atrophy,
metaplasia, and gastric cancer. Prog Mol Biol Transl Sci.
96:117–131. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
96
|
Mills JC and Goldenring JR: Metaplasia in
the stomach arises from gastric chief cells. Cell Mol Gastroenterol
Hepatol. 4:85–88. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
97
|
Coussens LM and Werb Z: Inflammation and
cancer. Nature. 420:860–867. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
98
|
Mantovani A, Allavena P, Sica A and
Balkwill F: Cancer-related inflammation. Nature. 454:436–444. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
99
|
Cancer Genome Atlas Research Network, .
Comprehensive molecular characterization of gastric adenocarcinoma.
Nature. 513:202–209. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
100
|
Cristescu R, Lee J, Nebozhyn M, Kim KM,
Ting JC, Wong SS, Liu J, Yue YG, Wang J, Yu K, et al: Molecular
analysis of gastric cancer identifies subtypes associated with
distinct clinical outcomes. Nat Med. 21:449–456. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
101
|
Banks M, Graham D, Jansen M, Gotoda T,
Coda S, di Pietro M, Uedo N, Bhandari P, Pritchard DM, Kuipers EJ,
et al: British society of gastroenterology guidelines on the
diagnosis and management of patients at risk of gastric
adenocarcinoma. Gut. 68:1545–1575. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
102
|
Sung JK: Diagnosis and management of
gastric dysplasia. Korean J Intern Med. 31:201–209. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
103
|
Song L and Yu QY: Stratified management of
residual gastric cancer risk after Helicobacter pylori
eradication. Front Microbiol. 17:17794902026. View Article : Google Scholar : PubMed/NCBI
|
|
104
|
Ding T, Hu W, Qi X, Zhang Y and Wang H:
Advances in Helicobacter pylori-mediated oncogenic signaling
pathways in gastric cancer: From pathological evolution to clinical
application prospects (Review). Oncol Lett. 32:4082026. View Article : Google Scholar : PubMed/NCBI
|
|
105
|
Guan Z, Han L, Chen B, Ma Y, Ni Q, Wang Z,
Yang J and Liu Z: Tumor microenvironment in gastric cancer immune
tolerance and its therapeutic relevance in immunomodulation
(Review). Oncol Lett. 31:1082026. View Article : Google Scholar : PubMed/NCBI
|
|
106
|
Moncada R, Barkley D, Wagner F, Chiodin M,
Devlin JC, Baron M, Hajdu CH, Simeone DM and Yanai I: Integrating
microarray-based spatial transcriptomics and single-cell RNA-seq
reveals tissue architecture in pancreatic ductal adenocarcinomas.
Nat Biotechnol. 38:333–342. 2020. View Article : Google Scholar : PubMed/NCBI
|